COHANCE LIFESCIENCES
Back to Balance Sheet
|
COHANCE LIFESCIENCES Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹1,150 Cr | ₹1,053 Cr | ₹1,136 Cr | ₹852 Cr | ₹918 Cr |
What is the latest Net Current Assets ratio of COHANCE LIFESCIENCES ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹1,150 Cr |
| Mar2025 | ₹1,053 Cr |
| Mar2024 | ₹1,136 Cr |
| Mar2023 | ₹852 Cr |
| Mar2022 | ₹918 Cr |
How is Net Current Assets of COHANCE LIFESCIENCES Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,150 Cr | 9.27 | |
| Mar2025 | ₹1,053 Cr | -7.31 | |
| Mar2024 | ₹1,136 Cr | 33.27 | |
| Mar2023 | ₹852 Cr | -7.12 | |
| Mar2022 | ₹918 Cr | - | |
Compare Net Current Assets of peers of COHANCE LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| COHANCE LIFESCIENCES | ₹17,194.0 Cr | 0.1% | 3.8% | -49% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,826.0 Cr | -2.9% | -2.3% | 21.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,019.0 Cr | -1.6% | 9.8% | 51.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,875.0 Cr | -2.6% | -2.3% | 37.5% | Stock Analytics | |
| CIPLA | ₹112,773.0 Cr | -2.2% | -6.1% | -12.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,570.9 Cr | -0.9% | -1.8% | -9.8% | Stock Analytics | |
COHANCE LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| COHANCE LIFESCIENCES | 0.1% |
3.8% |
-49% |
| SENSEX | -1.1% |
-3.6% |
-5.3% |
You may also like the below Video Courses